Monday, December 7, 2009

Lifeline Biotech (PINK:LLBO): A crapshoot or a great deal for investors?


Lifeline Biotechnologies is developing a non-imaging technology called First Warning™ for breast cancer detection.


The company is currently trading at 0.0034

Lifeline Biotechnologies, Inc.
(Pink: LLBO)
1325 Airmotive Way
Suite 175
Reno, NV 89502
Phone: 775-324-1933
Fax: 775-852-7551
Web Site: http://www.lbti.com

Articles and items written about LLBO:

Daily Pharma Watch, November 30, 2009: Lifeline Biotech (LLBO)

FavStocks, October 26, 2009: Lifeline Estimates Six Months For FDA Response

BioMed Reports, August 3, 2009: FDA Calendar Extreme Trades: Aethlon (AEMD.OB), Lifeline (LLBO.PK)

VFC's STOCK HOUSE, July 28, 2009: VFC's Take on Lifeline Biotech

Todays Financial News.com, July 23, 2009: Interesting volume spikes precede rise in Lifeline Biotechs

I briefly wrote back in September that people should consider LLBO. The stock is still so cheap that you can get a lot shares for relatively little cost. The potential return is great, even if LLBO reaches just a penny. It may do a lot a better than that. Or it might tank. A lot depends on the FDA which has a bad habit of mucking things up with delays and over-regulation. But I've been buying shares of LLBO here and there with extra money I have available in my Zecco account. I encourage people to do their own research on LLBO and make their own choice.

No comments:

Post a Comment